Montreal, QUEBEC / TheNewswire / August 29, 2018 – On August 29, 2018, DMD Digital Health Connections Group Inc. (“DMD” or the “Company”) (NEX: DMG.H), filed its financial statements and MD&A reporting a profit of CAD$2.5 million on revenues of CAD$24.6 million for the six-month period ended June 30, 2018.

 

During the quarter ended June 30, 2018, the Company reported a profit of CAD$1.4 million on revenues of CAD$12.9 million while for the same period in 2017, the Company had generated a profit of CAD$0.4 million on revenues of CAD$12.1 million.

 

For the six-month period ended June 30, 2018, gross margin increased by CAD$0.5 million to CAD$15.7 million compared to the same period in 2017. For the quarter ended June 30, 2018, gross margin increased by CAD$0.9 million to CAD$8.3 million compared to the quarter ended June 30, 2017.

 

For the six-month period ended June 30, 2018 operating expenses were CAD$12.0 million compared to CAD$11.8 million during the same period in 2017. During the quarter ended June 30, 2018, operating expenses were CAD$6.2 million compared to CAD$6.3 million for the quarter ended June 30, 2017. The Company must continue its sales and marketing efforts and investment programs to develop new markets.

 

Complete financial statements and MD&A for the three-month period ended June 30, 2018 are available on SEDAR at www.sedar.com

About DMD Digital Health Connections Group Inc. (“DMD”)

DMD enables pharmaceutical, pharmaceutical marketing companies, digital advertising agencies and medical device companies to reach, message, connect and interact with US physicians and healthcare professionals via multiple access channels. Its service offerings provide targeted impressions and interactions through permission-based email, targeted on-line ad-serving, and mobile app advertising channels. Several pharmaceutical companies, agencies and healthcare organizations have adopted DMD's solutions to target, engage and interact with healthcare practitioners. For more information, visit www.dmdconnects.com.

Forward-looking statements

This news release contains forward-looking information. These statements relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management of DMD. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and DMD does not assume any obligation to update or revise them to reflect new events or circumstances.

 

Neither NEX, the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

-30-

Contact Information       

Laurel Hill Advisory Group North America Toll Free: 1-877-452-7184 Collect Calls Outside North America: 1-416-304-0211 Email: assistance@laurelhill.com